Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of β-arrestin2

Molecular Biology of the Cell

Volumn 22, Issue 9, 2011, Pages 1608-1616

  Yin, Chenlei ^a,b   Zhang, Ru ^a   Xu, Yongyu ^a,b   Chen, Qiuyan ^a,b   Xie, Xin ^a,b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; HISTIDINE; LIGASE INHIBITOR; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; N (( 3,3,3 TRIFLUORO 2 TRIFLUOROMETHYL)PROPIONYL)SULFANILAMIDE; PROTEIN MDM2; RECEPTOR PROTEIN; RING FINGER PROTEIN; SERINE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; ARRESTINS; CELL LINE; CELL NUCLEUS; CYTOPLASM; CYTOSOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MICROSCOPY, FLUORESCENCE; MUTATION; PROTO-ONCOGENE PROTEINS C-MDM2; RING FINGER DOMAINS; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 79955491663     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-09-0779     Document Type: Article

References (32)

1. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Pineyro G (2003). Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 100, 11406-11411. (Pubitemid 37205948)
2. Boularan C et al. (2007). Beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proc Natl Acad Sci USA 104, 18061-18066. (Pubitemid 350210820)
3. Boyd SD, Tsai KY, Jacks T (2000). An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2, 563-568.
4. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275, 8945-8951. (Pubitemid 30180252)
5. Ferguson SS (2001). Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53, 1-24.
6. Ferguson SS, Downey WE, 3rd, Colapietro AM, Barak LS, Menard L, Caron MG (1996). Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271, 363-366.
7. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, Lefkowitz RJ, Larsson O (2005). β-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem 280, 24412-24419. (Pubitemid 40934525)
8. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, Girnita A, Lefkowitz RJ, Larsson O (2007). Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem 282, 11329-11338. (Pubitemid 47100796)
9. Honda R, Tanaka H, Yasuda H (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25-27. (Pubitemid 28037193)
10. Jones SN, Roe AE, Donehower LA, Bradley A (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
11. Kang J et al. (2005). A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123, 833-847. (Pubitemid 41721030)
12. Lai Z et al. (2002). Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors. Proc Natl Acad Sci USA 99, 14734-14739. (Pubitemid 35334553)
13. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS (1999). The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 96, 3712-3717. (Pubitemid 29168975)
14. Lefkowitz RJ, Shenoy SK (2005). Transduction of receptor signals by betaarrestins. Science 308, 512-517.
15. Lin FT, Miller WE, Luttrell LM, Lefkowitz RJ (1999). Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem 274, 15971-15974.
16. Luan B, Zhang Z, Wu Y, Kang J, Pei G (2005). Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. EMBO J 24, 4237-4246. (Pubitemid 41828899)
17. Lukashchuk N, Vousden KH (2007). Ubiquitination and degradation of mutant p53. Mol Cell Biol 27, 8284-8295. (Pubitemid 350234240)
18. Luttrell LM et al. (1999). Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.
19. Luttrell LM, Lefkowitz RJ (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115, 455-465. (Pubitemid 34182973)
20. Ma L, Pei G (2007). Beta-arrestin signaling and regulation of transcription. J Cell Sci 120, 213-218.
21. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ (2000). Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577.
22. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
23. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S, Benmerah A (2002). Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 277, 37693-37701.
24. Shenoy SK, Lefkowitz RJ (2003). Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375, 503-515. (Pubitemid 37433499)
25. Shenoy SK, Lefkowitz RJ (2005). Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280, 15315-15324. (Pubitemid 40562888)
26. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ (2001). Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294, 1307-1313. (Pubitemid 33063090)
27. Shenoy SK, Modi AS, Shukla AK, Xiao K, Berthouze M, Ahn S, Wilkinson KD, Miller WE, Lefkowitz RJ (2009). Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci USA 106, 6650-6655.
28. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM (2002). beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277, 9429-9436. (Pubitemid 34953029)
29. Trotman LC et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141-156. (Pubitemid 46048885)
30. Wang P, Gao H, Ni Y, Wang B, Wu Y, Ji L, Qin L, Ma L, Pei G (2003a). Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem 278, 6363-6370. (Pubitemid 36800895)
31. Wang P, Wu Y, Ge X, Ma L, Pei G (2003b). Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278, 11648-11653. (Pubitemid 36792727)
32. Yue R, Kang J, Zhao C, Hu W, Tang Y, Liu X, Pei G (2009). Beta-arrestin1 regulates zebrafish hematopoiesis through binding to YY1 and relieving polycomb group repression. Cell 139, 535-546.